Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with

Suzanne D Vernon1, Toni Whistler, Barbara Cameron

  • 1Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. svernon@cdc.gov

BMC Infectious Diseases
|February 2, 2006
PubMed
Abstract

Insights

Post-infective fatigue following Epstein-Barr virus (EBV) infection is linked to altered gene expression. Key genes involved in immune response and mitochondrial function were differentially expressed in patients with persistent fatigue.

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • Acute infectious diseases often cause temporary symptoms like fever and fatigue.
  • Post-infective fatigue can persist long-term in some individuals after recovery.
  • Epstein-Barr virus (EBV) infection is a common cause of infectious mononucleosis and can lead to persistent fatigue.

Purpose of the Study:

  • To investigate gene expression differences in individuals experiencing post-infective fatigue after EBV infection.
  • To identify potential molecular correlates of persistent fatigue following acute mononucleosis.

Main Methods:

  • A pilot study involving 5 patients with post-infective fatigue (duration >6 months) and 5 matched controls.
  • Collection of peripheral blood mononuclear cell (PBMC) samples over a year.
  • Gene expression profiling using microarrays on extracted RNA.

Main Results:

  • Individuals with post-infective fatigue exhibited distinct gene expression profiles during acute infection compared to recovered controls.
  • Differential expression of genes such as ISG20, DNAJB2, CDK8, E2F2, and ACTN2 was observed.
  • Affected genes are involved in immune response, cell cycle regulation, and mitochondrial functions like fatty acid metabolism.

Conclusions:

  • Preliminary findings suggest altered gene transcription patterns are associated with post-infective fatigue after EBV.
  • These gene expression changes may offer insights into the mechanisms underlying persistent fatigue.
  • Further research is warranted to explore these molecular alterations and their clinical implications.